S'abonner

International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009 - 23/05/12

Doi : 10.1016/j.ajic.2011.05.020 
Victor D. Rosenthal, MD, MSc, CIC a, , Hu Bijie, MD b, Dennis G. Maki, MD c, Yatin Mehta, MD d, Anucha Apisarnthanarak, MD e, Eduardo A. Medeiros, MD f, Hakan Leblebicioglu, MD g, Dale Fisher, MD h, Carlos Álvarez-Moreno, MD i, Ilham Abu Khader, MD j, Marisela Del Rocío González Martínez, MD k, Luis E. Cuellar, MD l, Josephine Anne Navoa-Ng, MD m, Rédouane Abouqal, MD n, Humberto Guanche Garcell, MD o, Zan Mitrev, MD p, María Catalina Pirez García, MD q, Asma Hamdi, MD r, Lourdes Dueñas, MD s, Elsie Cancel, MD t, Vaidotas Gurskis, MD u, Ossama Rasslan, MD v, Altaf Ahmed, MD w, Souha S. Kanj, MD x, Olber Chavarría Ugalde, RN y, Trudell Mapp, RN z, Lul Raka, MD aa, Cheong Yuet Meng, MD bb, Le Thi Anh Thu, MD cc, Sameeh Ghazal, MD dd, Achilleas Gikas, MD ee, Leonardo Pazmiño Narváez, MD ff, Nepomuceno Mejía, MD gg, Nassya Hadjieva, MD hh, May Osman Gamar Elanbya, MD ii, María Eugenia Guzmán Siritt, MD jj, Kushlani Jayatilleke, MD kk

INICC members

a From the International Nosocomial Infection Control Consortium, Buenos Aires, Argentina 
b Zhongshan Hospital, Shanghai, China 
c University of Wisconsin Medical School, Madison, WI 
d Medanta the Medcity, New Delhi, India 
e Thammasat University Hospital, Pratumthani, Thailand 
f Hospital São Paulo, São Paulo, Brazil 
g Ondokuz Mayis University Medical School, Samsun, Turkey 
h National University Hospital, Singapore, Republic of Singapore 
i Hospital Universitario San Ignacio, Universidad Pontificia Javeriana, Bogotá, Colombia 
j Jordan University Hospital, Amman, Jordan 
k Instituto Mexicano del Seguro Social, Torreón, Mexico 
l Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru 
m St. Luke’s Medical Center, Quezon City, Philippines 
n Ibn Sina Medical ICU, Rabat, Morocco 
o Hospital Docente Clínico Quirúrgico “Joaquín Albarrán Domínguez,” Havana, Cuba 
p Filip II Special Hospital for Surgery, Skopje, Macedonia 
q Centro Hospitalario Pereira Rosell Bouar, Montevideo, Uruguay 
r Hôpital d’Enfants, Tunis, Tunisia 
s Hospital Nacional de Niños Benjamin Bloom, San Salvador, El Salvador 
t San Jorge Children’s Hospital, Asociación Epidemiólogos de Puerto Rico, Guaynabo, Puerto Rico 
u Hospital of Kaunas University of Medicine, Kaunas, Lithuania 
v Ain Shams Faculty of Medicine, Cairo, Egypt 
w Liaquat National Hospital, Karachi, Pakistan 
x American University of Beirut Medical Center, Beirut, Lebanon 
y Hospital Hotel La Católica, San José, Costa Rica 
z Clínica Hospital San Fernando, Panama City, Panama 
aa National Institute for Public Health of Kosova and Medical School, Prishtina University, Prishtina, Kosovo 
bb Sunway Medical Centre Berhad and Monash University Sunway Campus, Petaling Jaya, Malaysia 
cc Cho Ray Hospital, Ho Chi Minh City, Vietnam 
dd King Fahad Medical City, Riyadh, Saudi Arabia 
ee University Hospital of Heraklion, Heraklion, Greece 
ff Hospital Eugenio Espejo, Quito, Ecuador 
gg Hospital General de la Plaza de la Salud, Santo Domingo, Dominican Republic 
hh University Hospital “Queen Giovanna-ISUL,” Sofia, Bulgaria 
ii Bahry Accident and Emergency Hospital, Khartoum, Sudan 
jj Hospital Militar Dr Carlos Arvelo, Caracas, Venezuela 
kk Sri Jayewardenepura General Hospital, Nugegoda, Sri Lanka 

Address correspondence to Victor D. Rosenthal, MD, MSc, CIC, International Nosocomial Infection Control Consortium (INICC), Corrientes Ave 4580, Floor 11, Apt A, Buenos Aires 1195, Argentina.

Abstract

The results of a surveillance study conducted by the International Nosocomial Infection Control Consortium (INICC) from January 2004 through December 2009 in 422 intensive care units (ICUs) of 36 countries in Latin America, Asia, Africa, and Europe are reported. During the 6-year study period, using Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN; formerly the National Nosocomial Infection Surveillance system [NNIS]) definitions for device-associated health care-associated infections, we gathered prospective data from 313,008 patients hospitalized in the consortium’s ICUs for an aggregate of 2,194,897 ICU bed-days. Despite the fact that the use of devices in the developing countries’ ICUs was remarkably similar to that reported in US ICUs in the CDC’s NHSN, rates of device-associated nosocomial infection were significantly higher in the ICUs of the INICC hospitals; the pooled rate of central line-associated bloodstream infection in the INICC ICUs of 6.8 per 1,000 central line-days was more than 3-fold higher than the 2.0 per 1,000 central line-days reported in comparable US ICUs. The overall rate of ventilator-associated pneumonia also was far higher (15.8 vs 3.3 per 1,000 ventilator-days), as was the rate of catheter-associated urinary tract infection (6.3 vs. 3.3 per 1,000 catheter-days). Notably, the frequencies of resistance of Pseudomonas aeruginosa isolates to imipenem (47.2% vs 23.0%), Klebsiella pneumoniae isolates to ceftazidime (76.3% vs 27.1%), Escherichia coli isolates to ceftazidime (66.7% vs 8.1%), Staphylococcus aureus isolates to methicillin (84.4% vs 56.8%), were also higher in the consortium’s ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 7.3% (for catheter-associated urinary tract infection) to 15.2% (for ventilator-associated pneumonia).

Le texte complet de cet article est disponible en PDF.

Key Words : Network, Hospital infection, Nosocomial infection, Health care-associated infection, Device-associated infection, Ventilator-associated pneumonia, Catheter-associated urinary tract infection, Central line-associated bloodstream infection, Bloodstream infection, Urinary tract infection, Antibiotic resistance, Developing countries, Limited-resources countries, Low-income countries


Plan


 Victor D. Rosenthal and the Foundation to Fight Against Nosocomial Infections funds all of the activities at INICC headquarters (www.inicc.org).
 For a list of the remaining co-authors, members of the International Nosocomial Infection Control Consortium (INICC), see Appendix.
 Conflict of interest: None to report.


© 2012  Association for Professionals in Infection Control and Epidemiology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 40 - N° 5

P. 396-407 - juin 2012 Retour au numéro
Article précédent Article précédent
  • The relationship of public health to the infection preventionists in United States hospitals, 2011: A partnership for change
  • Rachel L. Stricof, Marilyn Hanchett, Jennifer Beaumont, Karen Kaiser, Denise Graham
| Article suivant Article suivant
  • Eight initiatives that misleadingly lower ventilator-associated pneumonia rates
  • Michael Klompas

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.